Electrical stimulation (ES) can activate diverse biostimulatory responses in a range of tissues. Of various forms of ES, the application of biphasic electric current (BEC) is a new approach to bone formation. This study is to investigate the effects and mechanism of action of BEC in osteoblast differentiation and cytokine production in human mesenchymal stromal cells (hMSCs). Using an in vitro culture system with a modified version of the BEC stimulator chip used in our previous study, we exposed hMSCs to a 100 Hz ES with a magnitude of 1.5=15 mA=cm 2 for 250=25 ms. hMSCs showed increased proliferation during static BEC stimulation for 5 days. However, alkaline phosphatase activity and calcium deposition were enhanced in hMSCs 7 days after the stimulation, rather than during the period of ES. BEC induced vascular endothelial growth factor (VEGF) and BMP-2 production; the former can enhance the proliferation of human umbilical vein endothelial cells in culture using conditioned media from BEC cultures. Treatment with selective inhibitors of p38 MAPK (SB203580) or Erk (PD98059), as well as calcium channel blockers (verapamil and nifedipine), reduced the BEC-mediated increase of VEGF expression and cell proliferation. These findings reveal that BEC is involved in the osteoblast differentiation of hMSCs through enhancement of cell proliferation and modulation of the local endocrine environment through VEGF and BMP-2 induction through the activation of MAPK (Erk and p38) and the calcium channel. Thus, local stimulation using BEC might be most beneficial in promoting osteogenic differentiation of hMSCs, resulting in enhanced bone formation for bone tissue engineering.
Introduction

E
lectrical stimulation (ES) is an efficient osteoinductive tool used in the treatment of diverse bone-related diseases, such as fresh fractures, osteoporosis, and joint pain. [1] [2] [3] Since Fukada and Yasuda proposed that electrical signals similar to those generated by mechanical stress could enhance fracture healing, 4 considerable laboratory and clinical research has demonstrated the therapeutic efficacy of various forms of ES, including direct current (DC), capacitative coupling (CC), combined magnetic fields, and pulsed electromagnetic fields (PEMF). 5, 6 With the abundance of in vitro and in vivo studies, PEMF has been applied to clinical trials and the successful outcomes have led to its widespread commercial availability. [7] [8] [9] However, each type of ES has some advantages and shortcomings in practical application. While the proliferative and angiogenic effects of PEMF result in enhanced bone regeneration, PEMF paradoxically can promote tumor progression in unexpected regions because PEMF affects a wide region. 10, 11 In contrast, a limited application type DC is more practical for bone regeneration in a specific area, such as with a dental implant, despite the difficult surgical requirements for the implantation of these devices.
In contrast to the noninvasive type of PEMF, DC is invasive and divided into a constant or a pulsatile type, the latter of which is either monophasic or biphasic. 12 Biphasic electric current (BEC) stimulation has generally been used in neural prosthetic devices and is used as a safe basic therapeutic tool to improve speech-processing strategies in cochlear implant patients. 13, 14 Pulsatile BEC can generate bio-favorable conditions through charge balance, resulting in the nonaccumulation of charged proteins, and maintenance of a constant current and pH in the media that cannot be achieved with constant DC. 12, 15, 16 Of the regulatory mechanisms in bone formation that are affected by electrical or mechanical stimulation, cytokine release from the bone cells or endothelial cells is a critical factor. There have been several reports that DC or CC stimulation can upregulate the expression of osteoinductive growth factor genes, including BMP-2, -4, and 7, transforming growth factor (TGF)-b1, and prostaglandin E2. [17] [18] [19] PEMF has been shown to stimulate the release of FGF-2 from endothelial cells, leading to the augmentation of angiogenesis through paracrine and autocrine changes in the surrounding tissue. 11 Vascular endothelial growth factor (VEGF) induction from bone cells has never been demonstrated with any other types of ES except for BEC, which was shown in our previous study. 12 VEGF secreted from osteoblasts functions as a paracrine factor and causes endothelial cells to proliferate and stimulate blood vessel formation in bone tissue. 20 Besides the basic function of carrying oxygen and nutrients to the developing bone, blood vessels play an active role in bone formation and remodeling by mediating the interaction between resident bone cells such as osteoblasts, osteocytes, osteoclasts, marrow stromal elements, and vascular cells at a variety of levels. 21, 22 Therefore, VEGF induction is tightly coupled to successful bone regeneration because angiogenesis is dependent on hypoxic stimuli and VEGF production. 23, 24 There has been one other report of upregulation of VEGF by ES in an animal experiment where skeletal muscle was chronically stimulated by electric current. 25 The effect of electricity on bone cell physiology leaves no doubt that electricity in its various forms can alter many cellular events. However, little is known about the signal transduction cascade that mediates the physiologic response of bone cells to ES, even with PEMF. Studies using CC field or IC field suggested that ES increases the intracellular calcium concentration via voltage-gated calcium channels, resulting in the activation of the calcium=calmodulin pathway that induces a proliferative response in bone cells. 18, 26 Another hypothesis is that gap junctions may also be regulated by electric fields, suggesting that intercellular communications may be modulated by biophysical stimuli. 26, 27 Recently, it was hypothesized that osteocytes, which play a pivotal role in new bone formation and bone remodeling, may be the sensory cells responding to ES to orchestrate the whole process of bone regeneration in response to electrotherapy for bone fractures. 28, 29 In a continuation of our previous study with rat calvarial osteoblasts, 12 we further investigated the effect of BEC on the osteoblast differentiation of and cytokine release from human mesenchymal stromal cells (hMSCs), and aimed to identify key components of the signal transduction cascade. In this study, we examined the osteoblast differentiation of hMSCs by assessing proliferation and alkaline phosphatase (ALP) activity, performing real-time reverse transcriptionpolymerase chain reaction (RT-PCR) of osteoblast-related genes and cytokines, and assessing mineral deposition. The signaling pathway activated by BEC was elucidated using selective inhibitors of MAPK, such as PD98059 (PD) for Erk and SB203580 (SB) for p38 MAPK, as well as the calcium channel blockers verapamil and nifedipine. The BEC stimulator integrated circuit chip used in the previous study was modified to deliver a wide range of electric currents with precise resolution.
Materials and Methods
Isolation and culture of hMSCs
Bone marrow was harvested from subjects after they gave their informed consent, and the study was approved by the local ethics committee (Institutional Review Board at Seoul National University Dental Hospital; No. CRI05008) according to the legal regulations for human tissue and organs in Korea. hMSCs (n ¼ 4; two men and two women aged from 19 to 24) were cultured according to the protocol described by Caterson et al. and Kim et al. 30, 31 The marrow suspension was collected in a syringe containing 6000 U=mL heparin and was mixed with PBS solution in the same volume ratio and centrifuged at 2500 rpm for 10 min. After aspiration of the upper PBS layer, the marrow suspension was layered on Ficoll-paque (Amersham Biosciences, Uppsala, Sweden) at 1:5 ratio, and centrifuged at 1200 g for 30 min. The nucleated cells concentrated at the interface were collected and washed with PBS. Adherent cells were plated at a density of 2Â10 6 cells=100 mm plate and cultured in an expansion medium containing low-glucose Dulbecco's modified Eagle's medium (DMEM), penicillin 100 units=mL, streptomycin 100 mg=mL, and 10% heat-inactivated fetal bovine serum (HIFBS) under a humidified atmosphere of 5% CO 2 at 378C. The medium was changed every 3 or 4 days. Cells were passaged when they reached 70% confluence, and second passage cells were used for the present experiments. To induce osteoblast differentiation, hMSCs were cultured by plating at a cell density of 1.7Â10 4 cells=cm 2 in a growth medium (high-glucose DMEM and 10% HIFBS) supplemented with ascorbic acid (50 mg= mL), b-glycerophosphate (10 mM), and dexamethasone (Dex; 10 nM), which were added at 1 or 2 days postplating when the cells were confluent. The commercial hMSCs (from a 22-year-old woman; Lonza, Walkersville, MD) were cultured in a specific culture medium provided from the company for maintenance, and in the same culture condition as primary hMSCs for ES.
BEC stimulation of hMSCs
The BEC stimulator was modified from the previously reported system so that the different parameters of the electrical current such as duration, amplitude, and pulse rate could be delivered with precise resolution using the chip (shown in Supplemental Fig. S1 , available online at www.liebertonline .com=ten). The in vitro culture system was the same as used in our previous study. 12 An Au-deposited silicon plate was used as a stimulating electrode as well as a culture plate due to its biocompatibility, excellent cell attachment, and high conductivity. All components of the in vitro culture system were handled as described in our previous study. hMSCs were stimulated at a frequency of 100 pulses=s, which is lower than the frequency of 3000 pulses=s that was used to stimulate rat calvarial osteoblasts previously used. Instead of reducing the pulse rate, the duration or amplitude was increased by 10-fold so that the same total charge number, as used for the rat calvarial osteoblasts, was injected. Therefore, the stimulation parameters were divided into two groups that had the same pulse rate of 100 pulses=s (250 ms duration 
Cell proliferation test
hMSCs were inoculated at a density of 2500 cells=cm 2 of gold surface in DMEM supplemented with 10% HIFBS. After 1 day, the cells were exposed to BEC. Proliferation was measured at days 1, 3, and 5 by counting after trypan blue staining. The control group was cultured in the same culture system without ES. The proliferation of human umbilical vein endothelial cells (HUVECs) was assessed using an Cell Counting Kit-8 (Dojindo, Tokyo, Japan), a simplified assay employing the tetrazolium salt, WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt], at days 1 and 2 after culturing in equally mixed medium with HUVEC-specific growth medium and conditioned media (CM) from either BEC or control cultures. CM was collected at day 7 with culture supernatants from the last 3 days of culture. The proliferation of HUVECs was repeated in triplicate with three or four independent samples (n ¼ 3-4).
RT-PCR and real-time RT-PCR
Total RNA was extracted by adding 0.5 mL of TRIzol reagent (Invitrogen-Life Technologies, Carlsbad, CA) to cell pellets. One microgram RNA from each sample was subjected to cDNA synthesis using SuperScript TM Reverse Transcriptase II (Invitrogen, Carlsbad, CA) and oligo (dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen) in a 20-mL reaction volume according to the manufacturer's instructions, with an additional step of removing RNA complementary to the cDNA using E. coli RNase H (Invitrogen). One microliter of cDNA was then subjected to PCR with the following amplification profile: predenaturation at 948C for 40 s, amplification (denaturation at 948C for 40 s, annealing at 608C for 40 s, and extension at 728C for 1 min) for a duration of 30 cycles, with a final extension at 728C for 10 min. PCR was performed in a DNA thermal cycler (model PTC-200; MJ Research, Waltham, MA). For each of the PCR products, 10 mL was electrophoresed on a 1.5% agarose gel in the presence of ethidium bromide and visualized by the Gel documentation system (Vilber Lourmat, Marne-la-vallee Cedex, France).
The human primer sequences were as follows:
Osteopontin (OPN; GenBank# J04765): forward, CAG GCT GAT TCT GGA AGT TCT GAG; reverse, ACT TTT GGG GTC TAC AAC CAG CAT Osteocalcin (OC; GenBank# X51699): forward, ATG AGA GCC CTC ACA CTC CTC; reverse, CTA GAC CGG GCC GTA GAA GCG Bone sialoprotein (BSP; GenBank# J05213): forward, GGC AGT AGT GAC TCA TCC GAA GAA; reverse, TTG TAG GTT CAA ACC CAC CAT TTG Type I collagen (Col I; GenBank# BC036531): forward, ACC TCA AGA GAA GGC TCA CGA TG; reverse, GCT GTT CTT GCA GTG GTA GGT GAT VEGF (GenBank# AF022375): forward, ACC ATG AAC TTT CTG CTG TCT TGG; reverse, TAC GTT CGT TTA ACT CAA GCT GCC b-Actin (GenBank# BC004251): forward, TAT CCA GGC TGT GCT ATC CCT GTA; reverse, GAT CTT GAT CTT CAT TGT GCT GGG For quantitative real-time RT-PCR, total RNA isolation and cDNA synthesis were carried out by the same method as RT-PCR. SYBR Ò Green PCR Master Mix (Applied Biosystems, Foster City, CA) was used to detect accumulation of PCR product during cycling with the ABI Prism 7700 sequence Detection system (Applied Biosystems). The thermocycling conditions were as follows: predenaturation at 958C for 10 min, amplification with denaturation at 958C for 15 s, and annealing and extension at 608C for 1 min for a duration of 30 cycles, with a final dissociation cycle at 958C for 15 s, 608C for 1 min, and 958C for 15 s. Real-time RT-PCRs were carried out in triplicate with three independent experiments (n ¼ 3). Oligonucleotide primers for real-time RT-PCR were designed for product sizes under 200 bp using real-time PCR system Sequence Detection Software v1.3 (Applied Biosystems), and primers were purchased from Bionics (Seoul, Korea). Fold differences of each gene were calculated for each treatment group using normalized C T values of housekeeping gene b-actin according to the instructions of Applied Biosystems.
The human primer sequences were as follows: 
ALP activity assay
ALP activity was determined by measuring the amount of p-nitrophenol produced using p-nitrophenol phosphate substrate using ALP assay kits (Sigma-Aldrich, St. Louis, MO). Cell lysates were mixed with alkaline buffer solution and gently shaken for 10 min. ALP substrate was added at RT for 30 min. After stopping the reaction with the addition of 0.05 N NaOH, the absorbance at 405 nm was read and compared to a standard curve prepared with p-nitrophenol standard solution. Enzyme activity was normalized to the protein concentration of the cell layer, which was measured using the Bio-Rad protein assay (Bio-Rad, Hercules, CA).
Enzyme-linked immunosorbent assay (ELISA) of VEGF=BMP-2
VEGF-A=BMP-2 levels in culture supernatants were determined using ELISA kits (Quantikine Ò ; R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. Cell culture supernatants at days 1, 2, 3, and 7 (VEGF) or days 3 and 7 (BMP-2) after ES either in osteogenic or in growth medium were added into 96-well ELISA plates after centrifugation. Standards for VEGF (0-500 pg=mL) and BMP-2 (0-20,000 pg=mL) were run in each series. After incubation, aspiration, and washing, either human VEGF-A conjugate (100 mL=well) or mouse=rat=human BMP-2 conjugates (200 mL=well) were added per manufacturer's instructions. The optical density of each well was determined within 30 min using a microplate reader set to a 450-nm wavelength correction for optical imperfections in the plate. The ELISA was repeated in triplicate with three or four independent samples (n ¼ 3-4).
Determination of Erk and p38 phosphorylation
hMSCs were lysed in RIPA buffer as described in a previous report. 12 Cell lysates (30 mg=lane) were subjected to Western blot assay. Phosphorylated=total Erk and p38 were recognized by anti-phospho Erk=Erk and phospho-p38=p38 antibodies (Cell Signaling Technology, Danvers, MA), respectively, followed by HRP-conjugated anti-mouse IgG (Biomeda, Foster City, CA) as a secondary antibody. Blots were visualized with a chemiluminescence detection system (ECL; Amersham Biosciences, Buckinghamshire, United Kingdom).
Determination of mineralization
Calcium deposition was determined using Alizarin red S staining. hMSCs were cultured in 24 wells for 21 days in osteogenic medium under static BEC stimulation. Cells were fixed in 70% ice-cold ethanol for 1 h, rinsed with doubledistilled H 2 O, and then stained with 40 mM Alizarin red S (pH 4.2) for 10 min with gentle agitation. After five repeated washings with double-distilled H 2 O, the cells were rinsed for 15 min with 1Â PBS with gentle agitation to remove nonspecific binding. The amount of Alizarin red stain bound to the mineral was quantified by de-staining each sample in 400 mL of 10 mM sodium phosphate containing 10% cetylpyridinium chloride (pH 7.0) for 20 min at room temperature with gentle agitation. The amount of stained Alizarin red S was determined by measuring absorbance at 570 nm and calculated according to the standard curve.
Western blotting of HIF-1a
hMSCs were lysed in RIPA buffer described by Kim et al.
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Cell lysates (30 mg=lane) were subjected to 8% SDSpolyacrylamide gel and transferred to PolyScreen PVDF membrane (PerkinElmer Life Sciences, Waltham, MA). The membranes were blocked with 5% nonfat dry milk in TBST buffer (0.1 M Tris-buffered saline [pH 7.5]=0.1% Tween) and probed with antibodies. The following antibodies were used in this study: polyclonal human=mouse anti-HIF-1a antibody diluted 1:100 with (AB1536; R&D Systems) monoclonal anti-b-actin (Sigma-Aldrich, St. Louis, MN). Primary antibodies were detected after incubation with HRP-conjugated anti-rabbit IgG (Zymed Laboratories, San Francisco, CA) for HIF-1a, HRP-conjugated anti-mouse IgG (Dako, Carpinteria, CA) for b-actin, and finally with an enhanced chemiluminescence detection system ECL (Amersham Biosciences, Buckinghamshire, United Kingdom) according to manufacturer's instructions.
Statistical analysis
Data are expressed as the mean AE standard error of the mean (SEM) of triplicate over three independent samples (n > 3) for the analyses of proliferation, ALP assay, Alizarin red S staining, ELISA, and real-time RT-PCR. All analyses were statistically analyzed by Students' t-test (two-tailed) using SigmaPlot (version 8.0) statistical analysis software. A p-value <0.05 was considered statistically significant.
Results
Proliferation of hMSCs
Primary hMSCs were exposed to two kinds of stimulation that varied either in duration or in amplitude with the same frequency (see Materials and Methods). This variation was performed to find the appropriate parameters for stimulation of cell activities with the same total charge capacity. The cells of group 1 were exposed to a current with a magnitude of 250 ms (duration) and 1.5 mA=cm 2 (amplitude), and group 2 was exposed to a magnitude of 25 ms (duration) and 15 mA=cm 2 (amplitude) at the same frequency of 100 pulses=s. Proliferation was observed by cell counting at days 1, 3, and 5 during static stimulation. As the days passed, the number of cells increased more rapidly in both of the stimulated groups than in the unstimulated control. The proliferation of electrically stimulated hMSCs increased significantly to 78% ( p < 0.05) and 53.5% ( p < 0.01) at days 3 and 5, respectively, in group 1 ( p < 0.01), and 40% ( p ¼ 0.07) and 22.5% ( p < 0.01) at days 3 and 5, respectively, in group 2, compared to proliferation in the unstimulated control (Fig.  1) . The proliferation observed for group 1 was almost twofold higher than that for group 2. This finding means that a longer duration of BEC with a low-level amplitude induces more proliferation than a shorter duration of BEC with a FIG. 1. Cell proliferation of human mesenchymal stromal cells (hMSCs) under static biphasic electric current (BEC) stimulation. Primary hMSCs were exposed to two kinds of magnitudes of BEC stimulation. Group 1 was exposed to a magnitude of 1.5 mA=cm 2 (amplitude) for 250 ms (duration), and group 2 was exposed to a magnitude of 15 mA=cm 2 (amplitude) for 25 ms (duration), with the same pulse rate of 100 Hz for each group. Proliferation was assessed by cell counting after trypan blue staining at days 1, 3, and 5 after BEC stimulation. Values are mean AE SEM; n ¼ 3-4. Significantly different from the control: *p < 0.05; **p < 0.01.
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high-level amplitude when the total net charge capacity is held constant. Therefore, we investigated the effects of BEC in subsequent experiments using the electrical parameters used for group 1.
Osteoblast differentiation of hMSCs under BEC stimulation
Osteoblast differentiation of hMSCs was investigated during or after BEC stimulation for 7 days in osteogenic medium. ALP activity, a marker for early osteoblast differentiation, was decreased during ES compared to the unstimulated control, but ALP activity peaked at day 10 after a 7-day period of stimulation ( Fig. 2A) . Protein concentration at each time point was higher in BEC-stimulated group than unstimulated control during culture period of 14 days, meaning that BEC enhanced cell proliferation even in differentiation condition. In contrast to the trends observed for ALP activity, RT-PCR of other osteoblast differentiationrelated makers such as OPN, OC, BSP, and Col I revealed that there was neither an apparent induction nor a reduction of these markers by BEC stimulation (Fig. 2B) . However, each marker was adequately expressed at each of the differentiation phases. OPN expression declined as time passed, and mRNA expression of BSP, which is known to be an important factor in matrix mineralization, began to increase at day 7 and was maintained to day 14. OC mRNA expression, a late differentiation marker, increased during the period from days 7 to 10. A slight increase in OPN and OC mRNA expression was observed at day 7 in the stimulated group. Matrix mineralization was determined by assessing the de-stained amount of Alizarin red S after Alizarin red S staining because microscopic observation of stained matrix was impractical due to the opacity of the gold plate used for cell culture (Fig. 2C) . The culture of hMSCs in differentiation media for 21 days accelerated the matrix mineralization as shown by the 60% increase in the amount of stained Alizarin red S compared to the staining observed for cultures in growth medium. Under culture in osteogenic medium, BEC significantly enhanced the calcium deposition to 20% ( p < 0.01) higher than that of the unstimulated control at day 21 after 7 days of BEC stimulation.
VEGF induction and production of other growth factors
Our previous study demonstrated that VEGF gene expression in differentiated rat osteoblasts is stimulated by BEC. To investigate whether this effect is reproduced in hMSCs under a frequency (100 Hz) lower than the previously used frequency (3000 Hz), VEGF gene expression was examined both at the transcriptional level and at the protein level using ELISA and RT-PCR=real-time RT-PCR. VEGF synthesis was significantly increased from day 1 after BEC stimulation in primary hMSCs cultured from three different donors (Fig. 3A) . Real-time RT-PCR analysis of VEGF gene expression was consistent with both the expression patterns of RT-PCR and the protein expression (Fig. 3B) . Another experiment using commercial hMSCs resulted in VEGF induction in growth medium as well as in osteogenic medium in the stimulated group with an increase of 37% and 32%, respectively, over that in the unstimulated group (Fig. 3C) . VEGF production in osteogenic medium was reduced to 54%
FIG. 2.
Effect of BEC on the osteoblast differentiation and mineralization of hMSCs. Commercial hMSCs were exposed to BEC stimulation (1.5 mA=cm 2 , 250 ms, and 100 Hz) for 7 days in osteogenic medium. (A) Alkaline phosphatase (ALP) activity (nmol=min=mg protein) was measured at days 3, 7, 10, and 14 during and after BEC stimulation for 7 days. The ALP activity after each treatment is presented in a bar form as the mean AE SEM with triplicate measurements in over three independent samples. Protein concentration at each time point was indicated in parallel in a dotted line for unstimulated control or a solid line for BEC-stimulated group. During BEC stimulation, ALP activity decreased with BEC stimulation, but increased at day 10 after BEC stimulation. Significantly different from the control: *p < 0.05; **p < 0.01. (B) Reverse transcription-polymerase chain reaction (RT-PCR) of other differentiation markers OPN, OC, BSP, and ColI was performed at the same time points as the ALP activity assay. BEC did not affect the transcriptional expression of these genes. To control for equal loading, b-actin expression was determined in each RT-PCR reaction. (C) Calcium deposition was determined by measuring the amount of stained Alizarin red S as detailed in the methods. Cells were exposed to BEC for 7 days in osteogenic medium. The mineralization of hMSCs was determined at day 21 after culture in growth medium (control), and in osteogenic medium with or without BEC stimulation. The calcium deposition was determined in the control group cultured in growth medium and in the unstimulated and stimulated groups cultured in osteogenic medium. Significantly different between the two groups: **p < 0.01. of VEGF secreted from BEC-stimulated cells cultured in growth medium due to Dex treatment, but BEC stimulation suppressed the inhibitory action of Dex. Primary and commercial hMSCs varied slightly in the timing of observed VEGF induction, which occurred from days 1 to 7 for the former, and only at day 7 for the latter.
We analyzed whether the increase in VEGF expression could affect the proliferation of HUVECs (endothelial cell line) (Fig. 3D) . CM from BEC stimulation and control cultures in growth medium was prepared by mixing equal amounts of normal HUVEC-specific culture media and CM. As a positive control, HUVECs were cultured in media supplemented with exogenous VEGF (2 ng=mL). The proliferation of the HUVECs was significantly increased by 66% and 44% at days 1 and 2 in CM from BEC culture compared to CM from the control culture. This increase was higher than that observed in cells treated with exogenous VEGF (2 ng=mL), which resulted in a 44% and 22% increase at days 1 and 2 over CM from control culture, respectively. The proliferation of HUVEC cultured in a regular growth medium was greatly behind the other tested groups during two culture days.
We further examined the effect of BEC on other osteogenic cytokines such as IGF-1, TGF-b1, and BMP-2 using real-time RT-PCR. While VEGF mRNA expression increased with time, the gene expression of the other osteogenic cytokines declined. However, IGF-1 and TGF-b1 mRNA expression were slightly increased by BEC stimulation at days 2-3 and days 3 and 7, respectively (Fig. 4A, B) . BMP-2 mRNA expression showed brief upregulation only at day 3, and expression disappeared at day 7 (Fig. 4C ). An ELISA for BMP-2 was consistent with the patterns observed with real-time RT-PCR, and BMP-2 expression showed an 11% increase with BEC stimulation compared to the unstimulated control at day 3 (Fig. 4D ).
Cellular signaling mediated by BEC stimulation
The cellular signaling mechanism induced by BEC stimulation is unknown. We therefore performed experiments to elucidate the cellular signaling pathway using commercial hMSCs derived from one donor and cultured to passages 10-12. We investigated the relevance of the MAPK pathway (Erk and p38) and calcium channels in BEC-induced signaling using selective inhibitors to characterize the involvement of the corresponding pathways in BEC-mediated VEGF expression or cell proliferation. We found that BEC stimulation increased Erk and p38 activation in 30 min, as shown by immunoblots for phosphorylation (Fig. 5A) . Using a VEGF ELISA, we analyzed VEGF expression at day 7 after a 3-day pretreatment with each inhibitor and found that VEGF production was significantly decreased by 31.6% and 40.6% after treatment with the MAPK inhibitors, PD and SB, respectively, in comparison to untreated BEC-stimulated cells (Fig.  5B) . Real-time RT-PCR for VEGF mRNA expression showed a similar downregulation to that observed by ELISA in the   FIG. 3 . Vascular endothelial growth factor (VEGF) release from hMSCs after exposure to BEC. (A) Primary hMSCs were exposed to static BEC stimulation (1.5 mA=cm 2 , 250 ms, and 100 Hz) in growth medium at the same magnitude as Figure  2 . Secreted VEGF concentrations were quantified in cell culture supernatants (n ¼ 4) at days 1, 2, 3, and 7 using a VEGF ELISA kit. (B) VEGF mRNA expression was determined at days 1, 2, 3, and 7 after BEC stimulation by real-time RT-PCR=RT-PCR under the same condition as in (A) (C, unstimulated control; E, electrically stimulated by BEC). (C) Comparison of VEGF release from commercial hMSCs grown in growth medium or in osteogenic medium supplemented with Dex (10 nM) at day 7. BEC stimulation significantly induced VEGF production in both conditions. (D) Using conditioned media (CM) from the BEC culture, the proliferation of HUVECs (endothelial cells) was examined by MTT assay. The culture medium of HUVEC was prepared by mixing equal amounts of HUVEC-specific growth media and CM. HUVEC proliferation in CM from BEC cultures was compared to that in CM from control cultures, in cultures receiving exogenous VEGF treatment (2 ng=mL), or in control growth medium at days 1 and 2 after culturing. Significant difference between the two groups: *p < 0.05; **p < 0.01.
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FIG. 4. Gene expression of other regenerative cytokines (IGF-1, TGF-b1, and BMP-2).
(A) Commercial hMSCs were cultured under static BEC stimulation using the same conditions as in Figure 3A .
Transcriptional expression of IGF-1 (A), TGF-b1 (B), and BMP-2 (C) was quantified by real-time RT-PCR at days 1, 2, 3, and 7 after BEC stimulation (1.5 mA=cm 2 , 250 ms, and 100 Hz). The expression of IGF-1 and TGF-b1 decreased as time passed but showed a slight increase with BEC stimulation. BMP-2 mRNA expression showed a small increase at day 3. (D) BMP-2 release detected by ELISA showed a significant induction in response to BEC stimulation only at day 3. Significant difference from control: *p < 0.05; **p < 0.01.
FIG. 5. BEC activates ERK and p38 pathways. (A)
To observe the activation of MAPK, Erk and p38, hMSCs in growth medium were exposed to BEC stimulation (1.5 mA=cm 2 , 250 ms, 100 Hz) for 30 min. Cell lysates were harvested and subjected to SDS-PAGE, and probed for phospho-Erk/Erk (p42/44) or phospho-p38/p38 antibodies by western blot analysis. (B) hMSCs in growth medium were exposed to static BEC stimulation (1.5 mA=cm 2 , 250 ms, 100 Hz) for 3 days prior to treatment with selective inhibitors. The cells were then treated with PD or SB (all 10 mM) with BEC stimulation for an additional 3 days. The same procedure was performed for control cultures without BEC stimulation. Culture supernatants from the last 3 days were analyzed for VEGF production by ELISA. BEC-mediated VEGF production was compared between cultures treated with or without each inhibitor. Real-time RT-PCR was performed to examine the effect of each inhibitor on the gene expression of VEGF (C) and HIF-1 a (D) after BEC stimulation under the same conditions as in (B). Significant difference from stimulated group without inhibitors, p* < 0.05, p** < 0.01. presence of each inhibitor under BEC stimulation (Fig. 5C) . Interestingly, mRNA expression of HIF-1a, which is known to be an upstream transcriptional factor for VEGF expression, 32 showed a similar expression pattern to that of VEGF in response to treatment with each inhibitor (Fig. 5D) . A slight increase of protein expression of HIF-1a was observed at 30 min after ES (Fig. 6) .
To check whether calcium channels are involved in BECmediated signals, we used the calcium channel blockers verapamil and nifedipine (Fig. 7) . Both inhibitors significantly decreased the VEGF production by 20% compared to that seen in untreated BEC-stimulated cells at day 7. These experiments also demonstrate that calcium channel blockers significantly suppress VEGF and HIF-1a mRNA expression in BEC-stimulated cells compared to untreated BEC-stimulated cells.
We examined whether MAPK pathways or calcium channels are involved in BEC-induced cell proliferation. We analyzed cell proliferation at day 5 after BEC stimulation, after treatment with selective inhibitors for last 3 days (Fig. 8) . We found that the effect of selective inhibitors on cell proliferation was consistent with the effect on VEGF expression; the decrease in proliferation after treatment with selective inhibitors was greater in the stimulated group than in the unstimulated group. All tested inhibitors selectively suppressed cell proliferation in the BEC-stimulated group, but not in the unstimulated group. Among inhibitors, calcium channel blockers affected cell proliferation more strongly than the MAPK inhibitors with 42.7%=50.1% suppression (verapamil= nifedipine) vs. 27.7%=27.5% suppression (PD=SB) compared to the stimulated group, respectively.
Discussion
The exact mechanism by which ES promotes bone metabolism is unknown despite its effect on bone regeneration. We were interested in elucidating the molecular mechanism by which BEC stimulates osteoblast differentiation and cytokine release in hMSCs. Elucidating the cellular response to ES requires an in vitro culture system where cells are exposed to the desired intensity of electric current by controlling diverse stimulation parameters, including amplitude, pulse duration, and pulse rate. The novel in vitro model system used in this study has been established as an easy and safe approach to investigate cellular and molecular responses to ES in cell culture. The in vitro application of ES also allows us to follow how cells respond to a range of stimulation parameters. hMSCs were stimulated at a low frequency of 100 pulses=s, which is lower than the 3000 pulses=s used for rat calvarial osteoblasts in our previous study. We aimed to use a lower frequency in this study because cell responses at high frequency show a lot of variation. Using a modified stimulator device, we adjusted the duration or amplitude to a 10-fold higher magnitude while reducing the pulse rate from 3000 to 100 pulses=s while maintaining a constant total charge number. The results with the newly adjusted parameters were similar to and even more efficient than those from our previous study.
The in vitro cultured hMSCs used in the present study are a suitable experimental model for studying the effect of BEC stimulation on osteoblast differentiation and cytokine release in humans. 33 The cell responses of primary hMSCs can be diverse, probably due to variation in individual cell properties or the heterogeneity of the population of BMSCs that may include osteoprogenitor cells in addition to undifferentiated stem cells. 31, 34 Nevertheless, primary hMSCs are a better model for a human response than other osteoblasts or a stem cell line derived from rodent animals even though there might be larger variation. The previously reported stimulatory effects of BEC on cell proliferation and VEGF expression were confirmed in the primary hMSCs culture system despite the inherent variation. We also performed experiments using commercial hMSCs obtained from a single donor and found similar results. In this study, BEC stimulation of primary hMSCs induced cell proliferation and VEGF expression. However, the commercial hMSCs were less sensitive to BEC, probably due to variation between individual donors.
In general, ES appears to have the greatest effect on osteoblast proliferation, 17, 35, 36 while the effect on osteoblast differentiation depends on the type of ES. It is now well known that cell proliferation before mineralization is a critical process for increasing bone mass. 37, 38 In the present study, cells were stimulated at a low frequency of 100 pulses=s rather than at the previously tested frequency of 3000 pulses=s. At the latter frequency, cell proliferation was increased to 31% over that of the unstimulated control on day 2 after stimulation, with a relatively high variation in the stimulated group. However, the proliferative effect at the lower frequency of 100 pulses=s showed less variation and could be maintained during a prolonged culture period of up to 5 days. We also determined that a long duration of low amplitude BEC is more effective at inducing proliferation than a shorter duration of high amplitude when the total net charge capacity remains equal. This result suggests that a lower frequency and higher duration are more suitable for increasing cell proliferation when the total net charge capacity is held constant. However, the appropriate stimulation parameters depend on the tissue type or application because the volume of each tissue or cell, which has its own membrane capacitance and resistance, determines a quantity FIG. 6. Protein expression of HIF-1 a. Commercial hMSCs were exposed to BEC (1.5 mA=cm 2 , 250 ms, 100 Hz) for 30 min in growth medium. HIF-1 a (118 kDa) protein level was determined by western blotting and b-actin was detected as internal control.
KIM ET AL.
of injected electric charge from external electrode, and that in turn determines the amount of membrane conductivity. Therefore, the effective charge or other parameters differ from specific types of tissues or cells. 39 For example, a relatively high frequency of 3000 Hz of biphasic ES is safely applied in cochlear implant patients for improved speechprocessing strategies. 13 BEC stimulation was mitogenic rather than osteoinductive because it did not increase the expression of any osteoblast differentiation markers during the period of stimulation. This finding is consistent with previous results from rat calvarial osteoblasts. However, we examined the cellular responses after a long period of stimulation of over 2 weeks. As expected from our previous study, ALP activity and calcium deposition increased after 7 days of stimulation. This finding suggests that BEC stimulation itself is unable to accelerate osteoblast differentiation, but BEC does seem to have an indirect effect on differentiation in the period after temporary BEC stimulation. The effect of BEC on osteoblast differentiation may be as a result of its effect on proliferation from the increased protein concentration of stimulated group even in the differentiation condition. Findings from our past and current experiments indicate that BEC may increase the proliferation of differentiated osteoblasts and stromal cells, producing an increase in bone density in animal studies.
Recently, our author group has performed an in vivo animal study using an electronic device around a dental implant in a canine mandibular model (in revision). The animal study resulted in a significant increase in new bone formation in the bone area and an increase in the bone-implant contact around the implant area after 7 days of BEC stimulation. The results of in vitro and in vivo studies suggest that BEC is an efficacious tool for target-specific osteoinductive therapy.
The ability to upregulate osteoinductive growth factors is shared by DC, IC, and CC fields. The expression of cytokines, TGF-b1, BMP-2, -4, and -7, and prostaglandin E2 is known to be induced in osteoblasts, or osteoblast-like cells stimulated by ES. [17] [18] [19] These growth factors may function to amplify the field effects through autocrine and paracrine signaling. The present study demonstrated VEGF induction at the protein and transcriptional level in hMSCs, which has also been confirmed in differentiated osteoblasts.
12 VEGF induction from osteoblasts or stromal cells has never been reported in a study using any types of ES other than BEC. It has been reported that PEMF increases blood vessel growth by inducing the release of bFGF from endothelial cells, but the induction of VEGF in osteoblasts or endothelial cells has never been shown in PEMF cultures. 11 This unique effect of BEC suggests that it may play a role in bone metabolism because angiogenesis is critical for bone regeneration and preferentially depends on VEGF production. Further, the finding that BEC enhances VEGF production under growth and osteogenic conditions indicates a novel mode of action for BEC, which may favor an angiogenic microenvironment before and during osteoblast differentiation. VEGF induction from BEC-stimulated cells is very intriguing given the use of local applications of VEGF to enhance healing and angiogenesis in animal bone defect models. [40] [41] [42] Although ES is definitely an efficient method for bone formation, characterizing the related molecular mechanisms is complicated because of the limited response of cells depending on the mode, strength, and duration of the applied
Involvement of a calcium channel-mediated pathway in BEC signaling. (A) Secreted VEGF concentration was assessed at day 7 as previously described in Figure 5B , after treatment with calcium channel blockers verapamil (Ver; 10 mM) or nifedipine (Nif; 10 mM). BEC-mediated VEGF production was compared between cultures treated with or without each inhibitor. VEGF (B) and HIF-1a (C) mRNA expression was determined using real-time RT-PCR with the same conditions as in (A). Significant difference between BEC-stimulated cultures with and without inhibitors: *p < 0.05; **p < 0.01.
FIG. 8.
BEC-stimulated cell proliferation in the presence of selective inhibitors. hMSCs were exposed to static BEC stimulation (1.5 mA=cm 2 , 250 ms, and 100 Hz) for 5 days and then treated with the selective inhibitors PD98059 (PD), SB203580 (SB) verapamil (Ver), and nifedipine (Nif ) (all 10 mM) for the last 2 days. Cell numbers were assessed by cell counting after trypan blue staining at day 5 after BEC stimulation. Significant difference between BEC-stimulated cultures with and without inhibitors: *p < 0.05; **p < 0.01.
ES.
14 It was hypothesized that BEC may be subjected to MAPK control. 43, 44 Experiments using selective inhibitors showed that Erk and p38 are both involved in VEGF induction and cell proliferation. 45 In particular, both MAPKs regulate VEGF as well as HIF-1a expression. Our previous study investigated the involvement of HIF-1a in BEC-mediated VEGF induction. While our previous study did not find an increase in synthesis and mRNA expression of HIF-1a, the present study demonstrated increased expression of HIF-1a by BEC stimulation. This discrepancy in results may be due to differences in cell type (rat calvarial osteoblasts vs. human stromal cells), or differences in BEC frequency (3000 Hz vs. 100 Hz). More reasonable explanation is the difference in the sampling time of cell lysate at day 4 in previous study versus 30 min in present study after ES because HIF-1a is subject to proteosomal degradation under normoxic conditions. 32 The present study revealed a strong relationship between VEGF production and HIF-1a expression in BEC-stimulated cells. Even though the present study could not prove that the BECmediated induction of HIF-1a mRNA expression came from a hypoxic stimulus, our results are consistent with recent reports that HIF-1a and VEGF expression are upregulated by the activation of MAPKs such as Erk and p38. 46, 47 Calcium signaling is known to play a major role in signal transduction activated by ES such as CC or IC fields. 18, 26 This type of stimulation acts through voltage-gated calcium channels and the release of activated calmodulin-dependent intracellular calcium stores. Several studies have already implicated calcium channels in the response to mechanical or ES, which induces a depolarization of the transmembrane potential that opens the calcium channels and induces a series of cellular activities such as synthesis of deoxyribonucleic acid, collagen, and noncollagenous proteins. 48, 49 In the present study, we demonstrated that BEC stimulation also propagates signals through calcium channels. Verapamil, a voltage-gated calcium channel blocker, and nifedipine, another calcium channel blocker known as an L-type calcium channel antagonist, 50 reduced the proliferative response and VEGF production in BEC-stimulated cells. Interestingly, we found that calcium signaling had a greater impact on cell proliferation than MAPK (Erk or p38) pathways in response to BEC stimulation. Further, the calcium channel blockers also suppressed VEGF and HIF-1a expression induced by BEC stimulation. Treatment with calcium channel blockers produced similar results to those observed after treatment with Erk and p38 inhibitor, reflecting that calcium signaling is involved in the induction of HIF-1a expression. These data suggest that BEC stimulation may mediate its effects by calcium ion translocation through voltage-gated calcium channels. However, we do not have any direct evidence that BEC stimulation results in the activation of calcium channels, which leads to an increase in prostaglandin, cytosolic calcium, or activated calmodulin.
In conclusion, BEC, a pulsatile type of DC, is a potential mitogenic signal that can induce regenerative cytokine production. In particular, BEC enhances VEGF release from hMSCs before and during osteoblast differentiation. The mechanism of BEC-induced osteoblast differentiation involves the activation of MAPKs (Erk and p38) and calcium channels, resulting in VEGF induction and cell proliferation. These findings reveal that BEC is involved in osteoblast differentiation of hMSCs by enhancing cell proliferation and inducing VEGF and BMP-2. The unique effect of BEC on VEGF induction supports its application in clinical cases requiring blood vessel formation.
